• F I S C A L First Quarter 2 0 2 3 FIRST QUARTER 2023 BIOCERES CROP SOLUTIONS FIRST QUARTER 2023 ര Bioceres Crop Solutions no 02 03 04 Disclaimer This Presentation is for informational purposes only and does not constitute an offer or invitation to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, assets, business, debt or other financial instruments of the Company or any of its affiliates, and shall not form the basis of any contract, nor shall it be construed in any man ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ◻ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ⌧ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2022 OR ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OR ◻ SHELL COMPANY REPORT PURSUANT TO SECTION ...

Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Consolidated financial statements as of and for the years ended June 30, 2022, 2021 and 2020. ര Bioceres Crop Solutions Report of independent registered public accounting firm F-3 Consolidated statements of financial position F-4 Consolidated statements of comprehensive income F-6 Consolidated statements of changes in equity F-8 Consolidated statements of cash flows F-9 INDEX Consolidated financial statements as of and for the years ended June 30, 2022, 2021 and 20 ...

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Q4 2022 Earnings Conference Call September 8, 2022 8:30 AM ET Company Participants Paula Savanti - Head of Investor Relations Federico Trucco - Chief Executive Officer Enrique López Lecube - Chief Financial Officer Conference Call Participants Ben Klieve - Lake Street Capital Markets Kemp Dolliver - Brookline Capital Markets Dmitry Silversteyn - Water Tower Research Operator Hello and welcome to the Bioceres Crop Solutions Fiscal Fourth Quarter 2022 Financial Resu ...

BIOCERES CROP SOLUTIONS • 02 04 F I S C A L Fourth Quarter & Full-Year 2 0 2 2 @ Bioceres Crop Solutions a 03 FOURTH QUARTER 2022 BIOCERES CROP SOLUTIONS FOURTH QUARTER 2022 Disclaimer Financial Information Presentation Forward-Looking Statements Use of Non-IFRS Financial Measures Copyrights and Trademarks Industry and Market Data This Presentation is for informational purposes only and does not constitute an offer or invitation to sell, a solicitation of an offer to buy, or a recommendation to purchase any ...

Investor Presentation NASDAQ: BIOX August 2022 ര Bioceres Crop Solutions Disclaimer | --- ...

Investor Presentation NASDAQ: BIOX June 2022 ര Bioceres Crop Solutions Disclaimer | --- ...

Exhibit 99.1 BIOCERES CROP SOLUTIONS CORP. Unaudited interim condensed consolidated financial statements as of March 31, 2022 and June 30, 2021, and for the three-and nine-month periods ended March 31, 2022, and 2021. ര Bioceres Crop Solutions Unaudited interim condensed consolidated statements of financial position as of March 31, 2022 and June 30, 2021 F-3 Unaudited interim condensed consolidated statements of comprehensive income for the three and nine-month periods ended March 31, 2022 and 2021 F-5 Unau ...

Marrone Bio Innovations, Inc. (MBII) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Kevin Helash – Chief Executive Officer Linda Moore – Chief Legal Officer LaDon Johnson – Interim Chief Financial Officer Matti Tiainen – Senior Vice President International Sales Kamal El Mernissi – Senior Director of Product & Marketing Conference Call Participants Dmitry Silversteyn – Water Tower Research Operator Good afternoon ladies and gentlemen, and welcome to the First Quarter 2022 Earn ...

Marrone® Bio Innovations Fourth Quarter and Full Year 2021 Results March 28, 2022 • NASDAQ: MBII Manage Worker Boost Yield Sustainable Resistance Flexibility and Quality Friendly Safe Harbor This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations and plans, and future financial performance, including assumptions underlying such statem ...